These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15476055)

  • 1. Transfusion risk for hepatitis B, hepatitis C and HIV in the state of Santa Catarina, Brazil, 1991-2001.
    Kupek E
    Braz J Infect Dis; 2004 Jun; 8(3):236-40. PubMed ID: 15476055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual transfusion risk for hepatitis B and C in southern Brazil, 1991-99.
    Kupek EJ
    J Viral Hepat; 2001 Jan; 8(1):78-82. PubMed ID: 11155155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of transfusion-transmitted infections in sub-Saharan Africa.
    Jayaraman S; Chalabi Z; Perel P; Guerriero C; Roberts I
    Transfusion; 2010 Feb; 50(2):433-42. PubMed ID: 19843290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
    Soldan K; Barbara JA; Ramsay ME; Hall AJ
    Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV-1, HBV, and HCV among patients admitted to the emergency department of the Hospital de Base of the Federal District, Brazil.
    Ribeiro J; Boaventura R; Moitinho RF; Moitinho NF; Campos KN; Silva RR; Câmara GN
    Infect Control Hosp Epidemiol; 2000 Sep; 21(9):558. PubMed ID: 11001254
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group.
    Regan FA; Hewitt P; Barbara JA; Contreras M
    BMJ; 2000 Feb; 320(7232):403-6. PubMed ID: 10669443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An overview of hepatitis B in Brazil and in the state of Santa Catarina].
    Chávez JH; Campana SG; Haas P
    Rev Panam Salud Publica; 2003 Aug; 14(2):91-6. PubMed ID: 14577931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil.
    de Carvalho HB; Mesquita F; Massad E; Bueno RC; Lopes GT; Ruiz MA; Burattini MN
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):84-92. PubMed ID: 8624766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
    Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood screening--the next generation in testing.
    Chappel RJ; Dax EM
    Aust N Z J Med; 1999 Dec; 29(6):763-4. PubMed ID: 10677118
    [No Abstract]   [Full Text] [Related]  

  • 15. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
    Ouattara H; Siransy-Bogui L; Fretz C; Diane KM; Konate S; Koidio A; Minga KA; Hyda J; Koffi-Abe N; Offoumou AM; Abissey S
    Transfus Clin Biol; 2006 Oct; 13(4):242-5. PubMed ID: 16822686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic transfusion hepatitis--an underestimated disease].
    Henschel M; Kilburg M; Feurle GE
    Med Klin (Munich); 1996 Jul; 91(7):438-41. PubMed ID: 8756110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.